90
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Low-molecular-weight sulfonated chitosan as template for anticoagulant nanoparticles

, , , , , , , & show all
Pages 4881-4894 | Published online: 30 Aug 2018

References

  • RabensteinDLHeparin and heparan sulfate: structure and functionNat Prod Rep200219331233112137280
  • WeitzDSWeitzJIUpdate on heparin: what do we need to know?J Thromb Thrombolysis201029219920719882363
  • BeniSLimtiacoJFLariveCKAnalysis and characterization of heparin impuritiesAnal Bioanal Chem2011399252753920814668
  • LiuHZhangZLinhardtRJLessons learned from the contamination of heparinNat Prod Rep200926331319240943
  • GunayNSLinhardtRJHeparinoids: structure, biological activities and therapeutic applicationsPlanta Med199965430130610364832
  • AlbanSFranzGPartial synthetic glucan sulfates as potential new antithrombotics: a reviewBiomacromolecules20012235436111749192
  • PaluckSJNguyenTHMaynardHDHeparin-mimicking polymers: synthesis and biological applicationsBiomacromolecules201617113417344027739666
  • BalanVVerestiucLStrategies to improve chitosan hemocompatibility: A reviewEur Polym J201453171188
  • MuzzarelliRATanfaniFEmanuelliMPaceDPChiurazziEPianiMSulfated N-(carboxymethyl)chitosans: novel blood anticoagulantsCarbohydr Res198412622252316713433
  • HiranoSTanakaYHasegawaMTobettoKNishiokaAEffect of sulfated derivatives of chitosan on some blood coagulant factorsCarbohydr Res19851372052153986847
  • FranzGAlbanSStructure-activity relationship of antithrombotic polysaccharide derivativesInt J Biol Macromol19951763113148789331
  • HuangRduYYangJFanLInfluence of functional groups on the in vitro anticoagulant activity of chitosan sulfateCarbohydr Res2003338648348912668103
  • Nud’gaLAPliskoEADanilovSNSynthesis and properties of sulfoethylchitosanZhurnal Prikl Khimi1974474872876
  • MuzzarelliRAAModified chitosans carrying sulfonic acid groupsCarbohydr Polym1992194231236
  • Nud’gaLAPetrovaVABen’kovichADPetropavlovskiiGAComparative study of reactivity of cellulose, chitosan, and chitin-glucan complex in sulfoethylationRuss J Appl Chem2001741145148
  • PestovAVPetrovaYSBukharovaAVSynthesis in a gel and sorption properties of N-2-sulfoethyl chitosanRuss J Appl Chem2013862269272
  • PetrovaYSBukharovaAVNeudachinaLKAdamovaLVKoryakovaOVPestovAVChemical properties of N-2-Sulfoethylchitosan with a medium degree of substitutionPolym Sci Ser B2014564487493
  • PetrovaYSNeudachinaLKMekhaevAVPestovAVSimple synthesis and chelation capacity of N-(2-sulfoethyl)chitosan, a taurine derivativeCarbohydr Polym201411246246825129768
  • PetrovaYSPestovAVUsoltsevaMKNeudachinaLKSelective adsorption of silver(I) ions over copper(II) ions on a sulfoethyl derivative of chitosanJ Hazard Mater201529969670126282087
  • ZhangKBrendlerEGebauerKGrunerMFischerSSynthesis and characterization of low sulfoethylated celluloseCarbohydr Polym2011832616622
  • FengTduYLiJHuYKennedyJFEnhancement of antioxidant activity of chitosan by irradiationCarbohydr Polym2008731126132
  • KumarBAVaradarajMCTharanathanRNLow molecular weight chitosan – preparation with the aid of pepsin, characterization, and its bactericidal activityBiomacromolecules20078256657217256986
  • ChaeSYJangMKNahJWInfluence of molecular weight on oral absorption of water soluble chitosansJ Control Release2005102238339415653159
  • BreitwieserDSpirkSFaslHDesign of simultaneous antimicrobial and anticoagulant surfaces based on nanoparticles and polysaccharidesJ Mater Chem B201311520222030
  • EhmannHMBreitwieserDWinterSGold nanoparticles in the engineering of antibacterial and anticoagulant surfacesCarbohydr Polym2015117344225498606
  • HolappaJNevalainenTSavolainenJSynthesis and characterization of chitosan N-betainates having various degrees of substitutionMacromolecules200437827842789
  • TravanAPelilloCDonatiINon-cytotoxic silver nanoparticle-polysaccharide nanocomposites with antimicrobial activityBiomacromolecules20091061429143519405545
  • MessmoreHLCoyneEWehrmacherWHDemirAMFareedJStudies comparing low molecular weight heparin with heparin for the treatment of thromboembolism: a literature reviewCurr Pharm Des20041091001101015078129
  • SeoPLockeCFCurrent and potential uses of low molecular weight heparin: a review and an economic analysisAm J Manag Care20006449850610977456
  • BrooksMBEvaluation of a chromogenic assay to measure the factor Xa inhibitory activity of unfractionated heparin in canine plasmaVet Clin Pathol200433420821415570557
  • RosénSCasoniMCHeparin therapy and monitoring: a role for the chromogenic antifactor Xa assayAm Clin Lab20012073538
  • EganGEnsomMHMeasuring anti-factor xa activity to monitor low-molecular-weight heparin in obesity: a critical reviewCan J Hosp Pharm2015681334725762818
  • ZiaAO’BrienSHGlobal coagulation assays: a clinical perspectiveJ Thromb Thrombolysis2015391899425244973
  • SuchmanALGrinerPFDiagnostic uses of the activated partial thromboplastin time and prothrombin timeAnn Intern Med198610468103706933
  • BatesSMWeitzJIAssaysCCoagulation assaysCirculation20051124e53e6016043649